John Meenan

1.9k total citations
55 papers, 1.2k citations indexed

About

John Meenan is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, John Meenan has authored 55 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 23 papers in Pulmonary and Respiratory Medicine and 15 papers in Oncology. Recurrent topics in John Meenan's work include Esophageal Cancer Research and Treatment (12 papers), Pancreatic and Hepatic Oncology Research (11 papers) and Gastric Cancer Management and Outcomes (10 papers). John Meenan is often cited by papers focused on Esophageal Cancer Research and Treatment (12 papers), Pancreatic and Hepatic Oncology Research (11 papers) and Gastric Cancer Management and Outcomes (10 papers). John Meenan collaborates with scholars based in United Kingdom, Netherlands and Russia. John Meenan's co-authors include G. N. J. Tytgat, Jeremy Sanderson, S J van Deventer, David Reffitt, Fuju Chang, Azhar Ansari, Andrew Y. F. Li Yim, Anthony M. Marinaki, Cesare Hassan and R. P. H. Thompson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Gut.

In The Last Decade

John Meenan

54 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Meenan United Kingdom 20 376 298 292 269 234 55 1.2k
Iván Guerra Spain 20 364 1.0× 144 0.5× 470 1.6× 174 0.6× 281 1.2× 73 1.0k
Hisashi Shiga Japan 18 306 0.8× 130 0.4× 388 1.3× 176 0.7× 297 1.3× 90 1.0k
Gary R. May Canada 19 1.2k 3.1× 470 1.6× 361 1.2× 678 2.5× 314 1.3× 81 1.7k
Paramjit Kaur India 15 292 0.8× 392 1.3× 384 1.3× 456 1.7× 152 0.6× 68 1.4k
A A M Lewis United Kingdom 16 692 1.8× 279 0.9× 322 1.1× 108 0.4× 214 0.9× 32 1.2k
Michael J. Burt New Zealand 18 419 1.1× 66 0.2× 417 1.4× 128 0.5× 512 2.2× 28 1.3k
Dino Veneri Italy 30 436 1.2× 281 0.9× 119 0.4× 183 0.7× 186 0.8× 93 2.2k
Yuga Komaki Japan 16 264 0.7× 139 0.5× 359 1.2× 149 0.6× 342 1.5× 47 882
R E Pounder United Kingdom 12 562 1.5× 65 0.2× 441 1.5× 229 0.9× 372 1.6× 18 1.2k
Raffaella Morotti United States 26 1.1k 2.9× 243 0.8× 215 0.7× 436 1.6× 558 2.4× 95 2.3k

Countries citing papers authored by John Meenan

Since Specialization
Citations

This map shows the geographic impact of John Meenan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Meenan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Meenan more than expected).

Fields of papers citing papers by John Meenan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Meenan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Meenan. The network helps show where John Meenan may publish in the future.

Co-authorship network of co-authors of John Meenan

This figure shows the co-authorship network connecting the top 25 collaborators of John Meenan. A scholar is included among the top collaborators of John Meenan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Meenan. John Meenan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meenan, John, et al.. (2022). Tocilizumab in the management of posttransfusion hyperhemolysis syndrome in sickle cell disease: The experience so far. Transfusion. 62(3). 546–550. 12 indexed citations
2.
Tsitsikas, Dimitris A., et al.. (2021). Successful treatment of acute sickle cell intrahepatic cholestasis with therapeutic plasma exchange. SHILAP Revista de lepidopterología. 2(1). 118–120. 5 indexed citations
3.
Dunn, Jason, Joanne L. Ooi, Fuju Chang, & John Meenan. (2012). PTU-207 Detection of dysplasia arising in Barrett's oesophagus is associated with better quality endoscopic technique: Abstract PTU-207 Table 1. Gut. 61(Suppl 2). A270.1–A270.
4.
Schizas, Alexis, Andrew B. Williams, & John Meenan. (2009). Endosonographic staging of lower intestinal malignancy. Best Practice & Research Clinical Gastroenterology. 23(5). 663–670. 12 indexed citations
5.
Kalaitzakis, Evangelos, et al.. (2008). Clinicians’ attitudes towards endoscopic ultrasound: A survey of four European countries. Scandinavian Journal of Gastroenterology. 44(1). 100–107. 22 indexed citations
6.
Kalaitzakis, Evangelos, et al.. (2008). Defining the lymph node burden in a Northern European population without malignancy: the potential effect of geography in determining a need for FNA?. Diseases of the Esophagus. 22(5). 409–417. 1 indexed citations
7.
Vu, Charles, et al.. (2007). The preferred choice for radial endosonographic staging of esophageal cancer: standard echoendoscope or nonoptic esophagoprobe?. Surgical Endoscopy. 21(9). 1617–1622. 6 indexed citations
8.
Meenan, John. (2006). Staging stenotic oesophageal tumours: Are CT and/or PET enough? Dilate or not?. Endoscopy. 38(S 1). 8–12. 1 indexed citations
9.
Meenan, John, et al.. (2004). The substitution of endoscopic ultrasound for endoscopic retrograde cholangio-pancreatography. European Journal of Gastroenterology & Hepatology. 16(3). 299–303. 11 indexed citations
10.
Meenan, John, et al.. (2003). Training in Radial EUS: What is the Best Approach and is There a Role for the Nurse Endoscopist?. Endoscopy. 35(12). 1020–1023. 27 indexed citations
11.
Tibble, Jeremy, John Meenan, Mark Wilkinson, & Alistair McNair. (2003). Biliary diverticula in sclerosing cholangitis. Gastrointestinal Endoscopy. 57(7). 918–918. 1 indexed citations
12.
Ansari, Azhar, Cesare Hassan, J. A. Duley, et al.. (2002). Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 16(10). 1743–1750. 198 indexed citations
13.
Meenan, John, et al.. (2001). What is the role of endoscopic ultrasound (EUS) following chemotherapy for esophageal carcinoma: Are we asking the right questions?. Gastrointestinal Endoscopy. 53(5). AB145–AB145. 1 indexed citations
15.
Meenan, John, et al.. (1997). Epithelial cell folate depletion occurs in neoplastic but not adjacent normal colon mucosa. Gastroenterology. 112(4). 1163–1168. 54 indexed citations
16.
Meenan, John, et al.. (1996). Influence of Sulfasalazine and Olsalamine on Colonic Epithelial Cell Folate Content in Patients with Ulcerative Colitis. Inflammatory Bowel Diseases. 2(3). 163–167. 4 indexed citations
17.
Meenan, John, Marcel L.C.M. Mevissen, Houshang Monajemi, et al.. (1996). Mechanisms underlying neutrophil adhesion to apical epithelial membranes.. Gut. 38(2). 201–205. 16 indexed citations
18.
19.
Meenan, John, Daan W. Hommes, Fibo J. ten Kate, et al.. (1996). Lexipafant (BB-882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis. European Journal of Gastroenterology & Hepatology. 8(6). 569–574. 24 indexed citations
20.
Meenan, John, Mark Schoeman, Erik A.J. Rauws, & K. Huibregtse. (1995). A video baby cholangioscope. Gastrointestinal Endoscopy. 42(6). 584–585. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026